The hemodynamic derangements in sepsis: Implications for treatment strategies

Chest

Volumn 114, Issue 3, 1998, Pages 854-860

  Marik, Paul E ^a   Varon, Joseph ^b  

^a SAINT VINCENT HOSPITAL   (United States)

^b NONE

Author keywords

Fluids; Hemodynamics; Lactate; Oxygen delivery; Pyruvate; Sepsis; Sepsis syndrome; Septic shock; Vasopressors

Indexed keywords

ANTIBIOTIC AGENT; HETASTARCH; HYPERTENSIVE FACTOR; LACTIC ACID; PYRUVIC ACID;

BLOOD VOLUME; CLINICAL TRIAL; COLLOID; CRYSTALLOID; HEMODYNAMICS; HUMAN; HYPOXIA; MORTALITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; TISSUE OXYGENATION; TISSUE PERFUSION;

EID: 0031668269     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3.854     Document Type: Article

References (109)

1. Hazinski MF, Iberti TJ, MacIntyre NR, et al. Epidemiology, pathophysiology and clinical presentation of Gram-negative sepsis. Am J Crit Care 1993; 2:224-235
2. Increase in national hospital discharge survey rates for septicemia-United States, 1979-1987. MMWR 1990; 39: 31-34
3. Centers for Disease Control and Prevention. Annual summary of births, marriages, divorces and deaths. United States, 1993. Mon Vit Stat Rep 1994; 42:4-10
4. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-123
5. Parrillo JE, Parker MM, Natanson C. Septic shock in humans: advances in understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113:227-242
6. Bone RC. Sepsis, the sepsis syndrome, multiorgan failure: a plea for comparable definitions. Ann Intern Med 1991; 114:332-333
7. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
8. Bone RC. A critical evaluation of the new agents for the treatment of sepsis. JAMA 1991; 266:1686-1691
9. Fein AM, Bernard GR, Criner GJ, et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, Deltibant (CP-0127). JAMA 1997; 277:482-487
10. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336:912-918
11. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25:1095-1100
12. Abraham E, Glauser MP, Butler T, et al. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: a randomized controlled multicenter trial. JAMA 1997; 277:1531-1538
13. Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. Lancet 1998; 351:929-933
14. Kreger E, Craven D, McCabe W. Gram-negative bacteremia: IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68:344-355
15. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 1995; 273:934-941
16. McCloskey RV, Straube RC, Sanders C, et al. Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5
17. Cohen J, Carlet J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit Care Med 1996; 24:1431-1440
18. Verhoef J, Hustinx H, Frasa H, et al. Issues in the adjunctive therapy of severe sepsis. J Antimicrob Chemother 1996; 38:167-182
19. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
20. Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996; 24:1072-1078
21. Pajkrt D, van Deventer SJ. The cellular response in sepsis. Curr Top Microbiol Immunol 1996; 216:119-132
22. Hayashi S, Gillian IC, Bondy G, et al. Molecular mechanisms of sepsis: molecular biology of the cell. J Crit Care 1997; 10:82-95
23. Bone RC. The sepsis syndrome: definition and general approach to management. In: Dorinsky PM, ed. Clinics in chest medicine. Philadelphia: WB Saunders, 1996; 175-182
24. Marsh CB, Wewers MD. The pathogenesis of sepsis: factors that modulate the response to Gram-negative bacterial Infection. In: Dorinsky PM, ed. Clinics in chest medicine. Philadelphia: WB Saunders, 1996; 183-198
25. Ognibene FP, Parker MM, Natanson C, et al. Depressed left ventricular performance: response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93:903-910
26. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
27. Pagani FD, Baker LS, Hsi C, et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 1992; 90:389-398
28. Ellrodt AG, Riedinger MS, Kimchi A, et al. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 1985; 110:402-409
29. Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
30. Natanson C, Fink MP, Ballantyne HK, et al. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 1986; 78:259-270
31. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357
32. Schreuder WO, Schneider AJ, Groenveld ABJ, et al. Effect of dopamine vs norepinephrine on hemodynamics in septic shock: emphasis on right ventricular performance. Chest 1989; 95:1282-1288
33. Hayes MA, Timmins AC, Yau EH, et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997; 25:926-936
34. Parker MM, Shelhamer JH, Natanson C, et al. Serial cardiovascular variables in survivors and nonsurvivors of septic shock: heart rate as an early predictor of prognosis. Crit Care Med 1987; 15:923-929
35. Metrangolo L, Fiorillo M, Friedman G, et al. Early hemodynamic course of septic shock. Crit Care Med 1995; 23:1971-1975
36. Astiz ME, Galera-Santiago A, Rackow EC. Intravascular volume and fluid therapy for severe sepsis. New Horiz 1993; 1:127-136
37. Carroll G, Snyder J. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 1982; 243:R131-R141
38. Rackow E, Kaufman B, Falk J. Hemodynamic response to fluid repletion in patients with septic shock. Circ Shock 1987; 22:11-22
39. Weil MH, Nishijima H. Cardiac output in bacterial shock. Am J Med Sci 1978; 64:920-923
40. James JH, Fang CH, Schrantz SJ, et al. Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle: implications for increased muscle lactate production in sepsis. J Clin Invest 1996; 98:2388-2397
41. Kagan BL, Baldwin RL, Munoz D, et al. Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 1992; 255:1427-1430
42. Cortez A, Zito J, Lucas C. Mechanism of inappropriate polyuria in septic patients. Arch Surg 1977; 172:471-476
43. Winslow C, Dorinsky PM. Regional blood flow distribution in endotoxin-treated dogs: modification by ibuprofen. J Crit Care 1994; 9:159-168
44. Fink MP, Cohn SM, Lee P, et al. Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: evidence of gut ischemia in a normodynamic model of septic shock. Crit Care Med 1989; 17:641-646
45. Booke M, Hinder F, McGuire R, et al. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 1996; 24:835-844
46. Brooke M, Hinder F, McGuire R, et al. Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow. Shock 1996; 5:362-370
47. 2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994; 76:793-800
48. Whitworth PW, Cryer HM, Garrison RN, et al. Hypoperfusion of the intestinal macrocirculation without decreased cardiac output during live Escherichia coli sepsis in rats. Circ Shock 1989; 27:111-122
49. Neviere R, Chagnon JL, Vallet B, et al. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med 1997; 25:1371-1377
50. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
51. Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol 1996; 91:1697-1710
52. 2 uptake during bacteremia in the dog. J Appl Physiol 1987; 63:1487-1489
53. Fink MP. Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 1993; 21:S4-S8
54. Fry DE. Multiple system organ failure. Surg Clin North Am 1988; 68:107-122
55. Marik PE. Gastric intramucosal pH: a better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104: 225-229
56. Zieglet TR, Smith RJ, O'Dwyer ST, et al. Increased intestinal permeability associated with infection in burn patients. Arch Surg 1988; 123:1313-1319
57. O'Dwyer ST, Mitchie HR, Ziegler TR, et al. A single dose of endotoxin increases intestinal permeability associated with infection in burn patients. Arch Surg 1988; 123:1459-1464
58. Johnston JD, Harvey CJ, Menzies IS, et al. Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 1996; 24:1144-1149
59. Fink MP, Kaups KL, Wang H, et al. Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery 1991; 110:154-161
60. VanderMeer TJ, Wang H, Fink MP. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995; 23:1217-1226
61. Drazenovic R, Samsel RW, Wylam ME, et al. Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia. J Appl Physiol 1992; 72:259-265
62. Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats [see comments]. Gastroenterology 1997; 113:1246-1257
63. Shoemaker WC, Appel PL, Waxman K, et al. Clinical trial of survivors cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients. Crit Care Med 1982; 10:398-403
64. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest 1988; 94:1176-1186
65. Edwards JD, Brown GCS, Nightingale P, et al. Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 1989; 17:1098-1103
66. Russell JA, Phang PT. The oxygen delivery/consumption controversy: approaches to management of the critically ill. Am J Respir Crit Care Med 1994; 149:533-537
67. Krebs HA, Woods HF, Alberti KGMM. Hyperlactataemia and lactic acidosis. Essays Med Biochem 1970; 1:81-103
68. Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetics failure in sepsis. JAMA 1992; 267:1503-1510
69. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995; 98:75-84
70. Lang CH, Dobrescu C. Gram-negative infection increases non-insulin mediated glucose disposal. Endocrinology 1991; 128:645-653
71. Zeller WP, The SM, Sweet M, et al. Altered glucose transporter in mRNA abundance in a rat model of endotoxic shock. Biochem Biophys Res Commun 1991; 176:535-540
72. Meszaros K, Lang CH, Bagby GJ, et al. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun 1987; 149:1-6
73. Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized, study. Intensive Care Med 1997; 23:282-287
74. Gore DC, Jahoor F, Hibbert JM, et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224:97-102
75. Gammaitoni C, Nasraway SA. Normal lactate/pyruvate ratio during overwhelming polymicrobial bacteremia and multiple organ failure. Anesthesiology 1993; 80:213-216
76. Ronco JJ, Fenwick JC, Wiggs BR, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993; 147:25-31
77. Song SK, Hotchkiss RS, Karl IE, et al. Concurrent quantification of tissue metabolism and blood flow via 2H/31P NMR in vivo: III. Alterations of muscle blood flow and metabolism during sepsis. Magn Reson Med 1992; 25:67-77
78. Hotchkiss RS, Song SK, Neil JJ, et al. Sepsis does not impair tricarboxylic acid cycle in the heart. Am J Physiol 1991; 260:C50-C57
79. Hotchkiss RS, Rust RS, Song SK, et al. Effect of sepsis on brain energy metabolism in normoxic and hypoxic rats. Circ Shock 1993; 40:303-310
80. Hotchkiss RS, Rust RS, Dence CS, et al. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol 1991; 261:R965-R972
81. Tresadern JC, Threlfall CJ, Wilford K, et al. Muscle adenosine 5′-triphosphate and creatine phosphate concentrations in relation to nutritional status and sepsis in man. Clin Sci 1988; 75:233-242
82. Boekstegers P, Weidenhofer S, Kapsner T, et al. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994; 22:640-650
83. Matuschak GM. Supranormal oxygen delivery in critical illness. New Horiz 1997; 5:233-238
84. Tuchschmidt J, Fried J, Astiz M, et al. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216-220
85. Yu M, Levy MM, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993; 21:830-838
86. Hayes MA, Timmins AC, Yau E, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
87. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032
88. Rackow EC, Astiz ME. Pathophysiology and treatment of septic shock. JAMA 1991; 266:548-554
89. Ognibene FP. Hemodynamic support during sepsis. Clin Chest Med 1996; 17:279-287
90. Flancbaum L, Dick M, Dasta J, et al. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997; 51:461-465
91. Falk JL, Rackow EC, Astiz ME, et al. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol 1988; 28:412-415
92. Rackow EC, Falk JL, Fein A, et al. Fluid resuscitation in circulatory shock: a comparison, of the cardiorespiratory effects of albumin, hetastarch, and saline infusions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11:839-850
93. Marik PE, Iglesias J, Maini B. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Intensive Care Med 1997; 12:51-55
94. Boldt J, Heesen M, Muller M, et al. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83:254-261
95. Morisaki J, Bloos F, Neal A. Colloid infusion preserves microvascular integrity better than crystalloid in hyperdynamic sepsis. Crit Care Med 1992; 20(suppl):S101
96. Zikria BA, King TC, Stanford J. A biophysical approach to capillary permeability. Surgery 1989; 105:625-631
97. Hakaim AG, Corsetti R. The pentafraction of hydroxyethyl starch inhibits ischemia-induced compartment syndrome. J Trauma 1994; 37:18-21
98. Myers GA, Conhaim RL, Rosenfeld DJ, et al. Effects of pentafraction and hetastarch plasma expansion on lung and soft tissue transvascular fluid filtration. Surgery 1995; 117: 340-349
99. Oz MC, Fitz Patrick MF, Zikria BA, et al. Attenuation of microvascular permeability dysfunction in postischemic striated muscle by hydroxyethyl starch. Microvasc Res 1995; 50:71-79
100. Connors AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996; 276:889-897
101. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
102. Diebel L, Wilson RF, Heins J, et al. End-diastolic volume versus pulmonary artery wedge pressure in evaluating cardiac preload in trauma patients. J Trauma 1994; 37:950-955
103. Reuse C, Vincent JL, Pinsky MR. Measurements of right ventricular volumes during fluid challenge. Chest 1990; 98:1450-1454
104. Krieger BE, Craven DE, McCabe WR. Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68:344-355
105. Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993; 270:1203-1210
106. Doglio GR, Pusajo JF, Egurdia MA, et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991; 19:1037-1040
107. Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992; 339:195-199
108. Ivatury RR, Simon RJ, Islam S, et al. A prospective randomized study of end points of resuscitation after major trauma: global oxygen transport indices versus organ-specific gastric mucosal pH. J Am Coll Surg 1996; 183:145-154
109. Kirton O, Civeta J, Hudson-Civatta J, et al. Gastric intramucosal pH (pHi) driven resuscitation and antioxidants: normalized pHi is associated with high survival. Crit Care Med 1998; 26(suppl):A142